ORASURE TECHNOLOGIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.86 USD | -3.67% |
|
-11.48% | -40.73% |
Presenter SpeechDaniel Brennan (Analysts)Welcome, Dan Brennan. Hopefully, you've been with us ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Calendar
2024-05-14
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
4.86
USD
Average target price
7.15
USD
Spread / Average Target
+47.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.73% | 372M | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
- Stock Market
- Equities
- OSUR Stock
- News OraSure Technologies, Inc.
- Transcript : OraSure Technologies, Inc. Presents at UBS Global Healthcare Virtual Conference 2021, May-26-2021 02